Private Wealth Management Group, LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 2011342
PRINCETON, NJ
Position in DNLI
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,613
+$1,930 QoQ
Shares Held
296
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#237
of 290 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Wealth Management Group, LLC holds $380,601 across 51 Biotechnology names. DNLI ranks #18 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60 | $37,412 | |
| 2 | INCY |
Incyte Corp
|
225 | $25,506 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
123 | $23,035 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
55 | $20,441 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40 | $19,869 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62 | $18,663 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
206 | $16,791 | |
| 8 | EXEL |
Exelixis, Inc.
|
287 | $15,615 |
All Filings in DNLI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,613 | 296 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,683 | 296 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,886 | 296 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,297 | 296 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,141 | 296 | Shares | Sole | 2025-07-29 | |
| 2024-12-31 | $5,298 | 260 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $7,573 | 260 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $6,037 | 260 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $492 | 24 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,051 | 49 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||